The effect of mycophenolate mofetil on primary and secondary treatment of primary glomerulonephritis and lupus nephritis


PAYDAŞ S., KURT C., TAŞKAPAN H., BALAL M., SERTDEMİR Y., Pembegul I.

INTERNATIONAL UROLOGY AND NEPHROLOGY, vol.41, no.1, pp.145-152, 2009 (SCI-Expanded) identifier identifier identifier

Abstract

Mycophenolate mofetil (MMF) has shown to be a reliable choice in the treatment of glomerulonephritis. We retrospectively reviewed the clinical course and response to MMF therapy in 49 patients with primary glomerulopathy (37 patients) and lupus nephritis [class III (five patients) and IV (seven patients)].